Video Game Based Digital Therapy Looks Promising in Pediatric ADHD Trial
Akili Interactive announced topline data from an open-label study (STARS-ADHD Adjunctive) of AKL-T01 for the treatment of attention deficit hyperactivity disorder (ADHD) in children with or without use of stimulants.
AKL-T01 is an investigational digital therapeutic that delivers a video game based treatment to help drive engagement and compliance in children living with ADHD. It utilizes the Company’s proprietary Selective Stimulus Management engine (SSME) to distribute sensory and motor stimuli to target and activate the prefrontal cortex of the brain.
Other Articles in this Edition
Will the FDA give the go-ahead to a prescription video game? The wait goes on, as new data come in
How to Address Mental Health In the Workplace
Report guides pediatricians in care of maltreated children, including pharmacotherapy
Scientists reveal ADHD medication’s effect on the brain
Video Game Based Digital Therapy Looks Promising in Pediatric ADHD Trial
ADHD, THE MUSIC BUSINESS, AND ME
Mix of stress and air pollution may lead to cognitive difficulties in children
Detroit Area Specialists Teach Women How to Thrive with ADHD
Scant evidence that pharmaceutical CBD or medicinal cannabis can reduce symptoms of mental disorders